Table 6 Class-I immunogenicity
From: Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Peptide | Position | Class-I immunogenecity |
|---|---|---|
LSPRWYFYY | 104–112 | 0.35734 |
RSRNSSRNS | 189–197 | 0.1499 |
IGYYRRATR | 84–92 | −0.00164 |
FTALTQHGK | 53–61 | −0.0226 |
KSAAEASKK | 249–257 | −0.07922 |
FPRGQGVPI | 66–74 | −0.26664 |